Ambrx Biopharma, Inc.

BARCLAYS PLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

3/25/2026

Shares

199,950

Value ($000)

2,847

Weight

0.0%

2023 Q4 - 2023 Q4 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	3/25/2026	2,847	0.0%	199,950	12/31/2023